Search clinical trials for: extended-release exenatide

Total 6553 results

AstraZeneca
Eli Lilly and Company

Completed

Study of the Safety of Substituting Exenatide for Insulin in Patients Using Insulin and Oral Antidiabetic Agents

Type 2 Diabetes Mellitus

United States
Cedars-Sinai Medical Center

Completed

Endoscopic Trigger Finger Release

Trigger Finger

United States
Maisonneuve-Rosemont Hospital

Recruiting

Visual Outcomes of Vivity in Patients With Well Controlled Glaucoma

Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)

Canada
Second Affiliated Hospital, School of Medicine,...

Completed

Safety and Effectiveness of Extended Circumferential Decompression for Thoracic Ossification of Posterior Longitudinal Ligament

Indications and Effectiveness for Extended Posterior Circumferential Decompression

China
Riphah International University

Recruiting

Effects of Active and PRT on Pain, Function and Temporospatial Gait Parameters in Runners With Plantar Fascitis

Pain | Gait | Plantar Fascitis

Pakistan
APOGEPHA Arzneimittel GmbH

Completed

Efficacy and Tolerability of Propiverine Hydrochloride in Patients With Neurogenic Detrusor Overactivity

Urologic Diseases | Urinary Incontinence | Urinary Bladder, Neurogenic | Neurogenic Urinary Bladder Disorder | Bladder Disorder, Neurogenic | Urinary Bladder Disorder, Neurogenic | Neurogenic Bladder Disorder | Urinary Bladder Neurogenic Dysfunction | Overactive Detrusor Function

Romania, Austria, Germany
Pfizer
ViiV Healthcare

Completed

Study to Estimate the Pharmacokinetics, Bioavailability and Effect of Food on Single Dose Modified-release Lersivirine 500 mg in Healthy Subjects

Healthy Volunteer

Belgium
NYU Langone Health
National Institute on Drug Abuse (NIDA)

Withdrawn

Assessing Optimal XR-Buprenorphine Initiation Points in Jail

Opioid Use Disorder

United States
George Thanassoulis
Jewish General Hospital; Laval University; Quebec Heart Institute

Withdrawn

Early Aortic Valve Lipoprotein(a) Lowering Trial (EAVaLL)

Aortic Stenosis and Lipoprotein(a) Levels

Canada
North Texas Veterans Healthcare System
National Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health...

Completed

Effect of Extended-Release Niacin on Saphenous Vein Graft Atherosclerosis (ALPINE-SVG)

Aortocoronary Saphenous Vein Bypass Graft Atherosclerosis | Intermediate Saphenous Vein Graft Lesions

United States
Sonova AG

Completed

Evaluation of Extended Wear Technology

Hearing Loss

United States
Barak Cohen, MD

Recruiting

The Role of Emotional and Orientation Support in Prevention of Postoperative Delirium Among Elderly Surgical Patients

Postoperative Delirium

Israel
Treatment Research Institute
National Institute on Drug Abuse (NIDA)

Completed

Clinical Monitoring to Facilitate Continuous Care for Substance Abusing Clients

Substance-Related Disorders | Mental Disorders

United States
Tianjin Medical University Cancer Institute and...

Completed

Selective Extended Dissection in Different Types of Pancreatic Head Cancer: A Retrospective Cohort Study.

Carcinoma, Pancreatic Ductal

China
Children's Hospital of Philadelphia
Rutgers University; NJ Dept of Health Commission on Cancer Research

Completed

Sleep in Pediatric HSCT

Sleep | Stem Cell Transplant Complications

United States
Hartford Hospital

Completed

Timing of Pessary Care

Pelvic Organ Prolapse

United States
Rijnstate Hospital

Unknown

Extended Pouch Roux-en-Y Gastric Bypass Study

Morbid Obesity

Netherlands
Dallas VA Medical Center

Completed

Minimization of Surgical Site Infections for Pts Undergoing Colorectal Surgery

Colorectal Surgery | Surgical Wound Infections

United States
NLS Pharmaceutics

Not yet recruiting

A Eight-Week Study of NLS-2 (Mazindol Extended Release) in Participants With Narcolepsy Type 1 (AMAZE)

Narcolepsy Type 1 | Narcolepsy With Cataplexy
XenoPort, Inc.

Completed

Polysomnography Study of GSK1838262 Extended Release Tablets Versus Placebo in RLS and Associated Sleep Disturbance

Restless Legs Syndrome | Restless Legs Syndrome (RLS)

United States
University of Miami

Terminated

Study of the Use of Niaspan for Treatment of Dyslipidemia in Diabetic Nephropathy

Diabetes Mellitus, Type 2 | Kidney Failure, Chronic | Hyperlipidemia

United States
University of Arkansas
National Institute on Drug Abuse (NIDA); Baylor College of Medicine

Completed

Doxazosin for Psychostimulant Dependence

Methamphetamine or Cocaine Dependence

United States
Sehat Medical Complex

Completed

Comparative Effect of Active Release Technique Versus Self-myofascial Release in Improving Piriformis Syndrome

Piriformis Syndrome

Pakistan
Cardenal Herrera University

Completed

Diaphragmatic Myofascial Release in Gastroesophageal Reflux Disease (GERD)

Gastroesophageal Reflux Disease

Spain
Heptares Therapeutics Limited
Quotient Clinical

Completed

Relative Bioavailability Study in Healthy Subjects to Evaluate the Pharmacokinetics of HTL0009936 After One Dose of Prototype Formulation

Alzheimer's Disease

United Kingdom
McGill University
Université de Montréal

Not yet recruiting

A Study to Assess the Safety, Tolerability, and Pharmacology of Darifenacin in Patients With ALS

Amyotrophic Lateral Sclerosis

Canada
Rothman Institute Orthopaedics

Completed

Local Intraoperative Analgesic Injection Versus Single Injection Interscalene Nerve Block in Patients Undergoing TSA

Osteoarthritis: Shoulder
Prof. Huss

Terminated

Adherence to Stimulant Treatment in Attention-Deficit Hyperactivity Disorder (ADHD) Patients (ASTA) (ASTA)

ADHD

Germany
Hoffmann-La Roche

Completed

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

Diabetes Mellitus Type 2

Sweden, United States, Mexico, South Africa, Russian Federation, France, Spain, Switzerland, Canada, Finland, New Zealand, Korea, Republic of, Thailand, Israel, Germany, Peru, Australia, Denmark, Italy, Ukraine, Greece, Puerto Rico, Guatemal... and more
AstraZeneca
Eli Lilly and Company

Completed

Effect of AC2993 Compared With Insulin Glargine in Patients With Type 2 Diabetes Also Using Combination Therapy With Sulfonylurea and Metformin

Diabetes Mellitus, Type 2

Belgium, United States, Australia, Portugal, Germany, Puerto Rico, Spain, Netherlands, Brazil, Finland, Norway, Poland, Sweden
Boehringer Ingelheim

Completed

Pharmacokinetics and Bioavailability Study of Lasolvan Hard Capsules and Effervescent Tablets in Healthy Volunteers

Healthy

Russian Federation
Xiangya Hospital of Central South University

Recruiting

Effects of GLP-1 RAs on Weight and Metabolic Indicators in Obese Patients

Obesity

China
AstraZeneca
Eli Lilly and Company; i3 Drug Safety

Completed

A Retrospective Cohort Study of Acute Pancreatitis in Relation to Use of Exenatide and Other Antidiabetic Agents

Type 2 Diabetes (Treated With Exenatide or Other Oral Antidiabetic Therapies) | Healthy Subjects (Treated With no Diabetes Therapies)

United States
Intarcia Therapeutics

Completed

Study of ITCA 650 (Exenatide in DUROS) in Subjects With Type 2 Diabetes Mellitus

Type 2 Diabetes

United States
AstraZeneca
Eli Lilly and Company

Completed

Efficacy of Once-Weekly Exenatide Versus Once or Twice Daily Insulin Detemir in Patients With Type 2 Diabetes

Type 2 Diabetes Mellitus

Ireland, United Kingdom
University of Chicago

Completed

Impact of Exenatide on Sleep Duration

Type 2 Diabetes

United States
Fundació Institut de Recerca de l'Hospital de la...
Instituto de Salud Carlos III

Recruiting

Identification and Clinical Relevance of an Oxytocin Deficient State (GLP1 Study)

Pituitary Diseases | Hypothalamic Diseases | Hypopituitarism | Social Isolation | Panhypopituitarism | Psychological Disorder | Central Diabetes Insipidus | Oxytocin Deficiency

Spain
National University Hospital, Singapore

Not yet recruiting

A Value-Driven Study on Reducing Immune Checkpoint Inhibitor Dosing Frequency in Advanced Cancers (VALUE-CHECK)

Carcinoma, Hepatocellular | Gastric Adenocarcinoma | Non-small Cell Lung Cancer | Head and Neck Squamous Cell Carcinoma | Oesophageal Cancer | GastroEsophageal Cancer

Singapore
Tris Pharma, Inc.
Premier Research Group plc

Completed

Amphetamine Extended-Release Tablets in the Treatment of Adults With ADHD

ADHD

United States
Abant Izzet Baysal University

Completed

The Effect of Suboccipital Release Technique in Individuals With Anxiety

Pain | Anxiety | Trapezius Muscle Strain

Turkey
GlaxoSmithKline
Quotient Clinical

Completed

A Study to Compare the Pharmacokinetics (PK) of GSK2982772 Following Administration of Different Modified Release (MR) Formulations in Capsule and MR Tablet Formulations Relative to an Immediate Release (IR) Tablet Formulation and to Check the PK of MR Formulation in Capsule Following Repeat Doses

Autoimmune Diseases

United Kingdom
GlaxoSmithKline
Quotient Sciences

Completed

A Study to Investigate the Pharmacokinetics (PK) of Modified Release (MR) Prototype Coated Tablet Formulations of GSK2982772

Autoimmune Diseases

United Kingdom
Chinese University of Hong Kong

Completed

Study of Open and Percutaneous Release of Acquired Trigger Thumb

Trigger Thumb

Hong Kong
Atlanta Diabetes Associates
Medtronic

Recruiting

Evaluation of Medtronic DUO Extended Set

Diabetes Mellitus, Type 1

United States
GlaxoSmithKline

Completed

Out-Patient Study in Patients With Type 2 Diabetes Mellitus Who Are Taking no Diabetes Medication or Metformin Only

Diabetes Mellitus, Type 2

United States, Dominican Republic, Chile
Daniel A. Siniawski
Merck Sharp & Dohme LLC

Terminated

Lipid Efficacy of the Extended Release Niacin/Laropiprant Combination in Patients With Cardiovascular Disease

Coronary Artery Disease | Dyslipidemias

Argentina
Yale University
National Institute on Drug Abuse (NIDA); Baystate Medical Center

Completed

Naltrexone for Opioid Dependent Released Human Immunodeficiency Virus Positive (HIV+) Criminal Justice Populations (NewHope)

HIV | Opioid Dependence | AIDS | Drug Dependence

United States
AstraZeneca
Eli Lilly and Company

Completed

Effects of Exenatide and Insulin Glargine in Subjects With Type 2 Diabetes

Type 2 Diabetes Mellitus

Finland, Netherlands, Sweden
Novo Nordisk A/S

Completed

The Efficacy of Insulin Degludec/Liraglutide in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on GLP-1 Receptor Agonist and OAD Therapy (DUAL™ III)

Diabetes Mellitus, Type 2 | Diabetes

United States, Slovakia, Hungary, France, Australia
Wu Qinan

Unknown

Study of Comparison the Treatment Effect Between Gastric Bypass and Exenatide in Type 2 Diabetes

Type 2 Diabetes

China

Search clinical trials for: extended-release exenatide

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bangladesh

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations